Navigation Links
PET scan distinguishes Alzheimer's from other dementia

SALT LAKE CITY A PET scan (positron emission tomography) that measures uptake of sugar in the brain significantly improves the accuracy of diagnosing a type of dementia often mistaken for Alzheimers disease, a study led by a University of Utah dementia expert has found.

The scan, FDG-PET, helped six doctors from three national Alzheimers disease centers correctly diagnose frontotemporal dementia (FTD) and Alzheimers in almost 90 percent of cases in the studyan improvement of as much as 14 percent from usual clinical diagnostic methods. FDG stands for fluorodeoxyglucose, a short-lived radioactive form of sugar injected into people during PET scans to show activity levels in different parts of the brain. In Alzheimers, low activity is mostly in the back part of the brain; in FTD, low activity is mostly in the front of the brain.

FDG-PET is an especially powerful tool in early treatment of FTD, said the studys lead author, Norman L. Foster, M.D., professor of neurology and director of the Center for Alzheimers Care, Imaging and Research at the University of Utah School of Medicine.

FTD is a common cause of early onset dementia among people 45-64 years old and is marked by behavioral changes and language difficulties. Like Alzheimers, it can take years to develop and, for now, is incurable. Although FTD is a separate disorder, it often meets clinical diagnostic criteria for Alzheimers and often is misdiagnosed even by dementia experts.

Early diagnosis of FTD can have a tremendous impact on the treatment for patients and their family members. Many patients are misdiagnosed and may be hospitalized and receive drugs for the wrong disease, Foster said. Accurate diagnosis bypasses the costs, side-effects, and frustration of misguided care. Furthermore, one-third of FTD patients have a family history of a similar disorder and family members need to know if they are at increased risk of the disease.

The study was funded by the National Institute on Aging, a part of the National Institutes of Health.

Dr. Fosters work involving patients from several NIA-sponsored Alzheimers Disease Centers advances the use of PET imaging as a clinical tool, said Creighton Phelps, Ph.D., program director of the Alzheimer Disease Centers at the National Institute on Aging. Combined with the patients medical history and psychometric testing, it enhances a physicians ability to more accurately distinguish between FTD and early-onset AD.

As the U.S. population ages, the number of people with dementia is projected to increase markedly, with Utah and the Intermountain West expected to experience the fastest rate of growth. Although FDG-PET is widely available, it is not often used in dementia, because of insurance concerns. Medicare recently agreed to pay for FDG-PET scans to evaluate dementia, but currently many insurance companies in the Intermountain West and Utah do not. Foster is working to make FDG-PET scans available to those who need them and results of this study prove they sometimes are worth doing.

This study shows FDG-PET is a reliable and valid diagnostic test that can aid physicians in making the sometimes difficult clinical distinction between AD (Alzheimers disease) and FTD, Foster and his co-authors wrote. But PET scans alone are not enough to confirm FTD or Alzheimers. A careful consideration of the medical history and examination will continue to be essential to dementia evaluation.

The study has appeared online in the journal Brain.

Foster and his colleagues examined the medical records and FDG-PET scans of 45 patients who later had autopsies. Microscopic examination found 31 had Alzheimers and 14 had FTD. The researchers summarized the clinical course of the disease in each patient. The expert neurologists at the NIH centers, who had 10 years to 25 years of experience, then were asked to decide what caused each patients dementia using clinical information alone or using FDG-PET images.

The experts correctly distinguished FTD and Alzheimers using only the clinical methods in 76 percent to 79 percent of the cases. Using the FDG-PET scans alone, however, the physicians correctly diagnosed the two dementias in 85 percent to 89 percent of cases. Adding FDG-PET to clinical information increased the correct diagnosis from 79 percent to 90 percent. The highest accuracy in diagnosis was achieved with SSP (stereotactic surface projection) displays, which summarize changes in brain activity and apply a statistical test to show significant areas of damage.

The PET scans also had other benefits. The researchers found in 42 percent of cases, the scans increased the experts confidence in a correct diagnosis or made them question and sometimes change an incorrect diagnosis.


Contact: Phil Sahm
University of Utah Health Sciences Center

Related medicine news :

1. Testing genes for disease does not cause harm to children of people with Alzheimers
2. Age-Dependent Alterations Not Specific For Alzheimers Disease
3. Killing two birds (cholesterol and Alzheimers disease) with the same stone
4. Exposure To High Aluminum Levels In Tap Water Lead To Rare Form Of Alzheimers
5. Sugar variant may make a world of difference to Alzheimers disease
6. Cancer Causing Protein May Heal Alzheimers
7. GAB2-A New Alzheimers Gene Identified
8. Emotional Stress Could Be a Factor in Causing Alzheimers: Study
9. Alzheimers Incidence is Set to Quadruple by 2050
10. Reduced Oxygen to the Brain Increases Alzheimers Risk in Stroke Victims
11. Magnets to the rescue of Alzheimers patients
Post Your Comments:
(Date:6/24/2016)... ... , ... Comfort Keepers® of San Diego, CA is excited to announce they ... to drive cancer patients to and from their cancer treatments. Comfort Keepers provides ... life and ongoing independence. Getting to and from medical treatments is one of ...
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... ... Haute Living, is proud to recognize Dr. Barry M. Weintraub as a prominent ... “the most beautiful women in the world, and the most handsome men, look ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... the Frederick area economy by obtaining investment capital for emerging technology companies. ... years that have already resulted in more than a million dollars of capital ...
(Date:6/24/2016)... ... June 24, 2016 , ... Venture Construction Group (VCG) ... held on June 20th at the Woodmont Country Club at 1201 Rockville Pike, ... organization dedicated to helping service members that have been wounded in battle and their ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/24/2016)... , June 24, 2016  Consumers have taken ... regulators/payers have placed more emphasis on patient outcomes. ... support programs in the pharmaceutical industry have evolved ... Consequently, pharmaceutical companies are focusing on becoming more ... providing products and services that improve health. ...
(Date:6/24/2016)... , June 24, 2016   Bay Area ... Network,s Dean Center for Tick Borne Illness ... and Rehabilitation, MIT Hacking Medicine, University of California, ... today announced the five finalists of Lyme ... disease.  More than 100 scientists, clinicians, researchers, entrepreneurs, ...
Breaking Medicine Technology: